Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System

Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System

Purpose: Patients with human epidermal growth factor receptor 2 (HER2) -positive metastatic tumors treated in the public health system in Brazil do not have access to trastuzumab. This study aimed to estimate the impact of the lack of access to anti-HER2 therapies on the mortality of these patients....

Full description

Bibliographic Details
Main Authors: Márcio Debiasi, Tomás Reinert, Rafael Kaliks, Gilberto Amorim, Maira Caleffi, Carlos Sampaio, Gustavo dos Santos Fernandes, Carlos H. Barrios
Format: Article
Language:English
Published: American Society of Clinical Oncology 2017-06-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.2016.005678

Internet

http://ascopubs.org/doi/10.1200/JGO.2016.005678

Similar Items